After excluding people with abnormal levels of FPG or HbA1C, the associations between IFNL3 polymorphisms with dyslipidemia became even stronger (OR = 5.56, 95%CI, 1.75–16.67, P = 0.001) (Table S4). The gene discussed is IFNL3; the disease is metabolic syndrome.